| Dec'19 | Dec'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Mar'14 |
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-6,718 | -9,449 | -14,891 | -16,998 | -14,347 | -5,280 | - |
Net loss | ||||||
- | - | - | - | - | - | -9,802 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Stock-based compensation | ||||||
66 | 234 | 1,700 | 901 | 2,118 | 195 | 144 |
Stock issued for services | ||||||
- | - | 56 | - | - | - | - |
Stock issued for license expense | ||||||
- | - | - | - | 1,200 | - | - |
Change in fair value of derivative instrument-warrants | ||||||
-398 | -5,322 | -4,224 | - | 387 | 3,595 | 8,846 |
Change in fair value of contingent consideration | ||||||
-160 | 265 | - | - | - | - | - |
Change in the fair value of debt | ||||||
179 | 108 | - | - | - | - | - |
Amortization of debt discount recorded as interest expense | ||||||
486 | - | - | - | - | - | - |
Non-cash interest for shares issued for debt redemption payments | ||||||
49 | - | - | - | - | - | - |
Change in fair value of derivative instrument-warrants and contingent consideration | ||||||
- | - | - | 3,806 | - | - | - |
Deferred taxes adjustment | ||||||
-341 | -536 | - | - | - | - | - |
Loss on the sale of fixed assets | ||||||
- | -4 | - | - | - | - | - |
Depreciation and amortization expense | ||||||
26 | 18 | 27 | 21 | 16 | 1 | - |
Changes in operating assets and liabilities: | ||||||
Accounts payable and accrued expense | ||||||
-424 | -897 | -2,128 | 3,135 | 1,516 | - | - |
Deferred rent liability | ||||||
- | -9 | - | - | - | - | - |
Accounts payable, accrued expenses and due to Synergy | ||||||
- | - | - | - | - | 294 | 245 |
Prepaid expenses and other assets | ||||||
330 | 82 | -287 | -191 | 563 | 168 | - |
Net cash used in operating activities | ||||||
-7,565 | -15,646 | -19,172 | -16,555 | - | - | - |
Prepaid expenses | ||||||
- | - | - | - | - | - | 117 |
Total Adjustments | ||||||
- | - | - | - | - | 3,917 | 9,118 |
Net Cash used in Operating Activities | ||||||
- | - | - | - | -9,672 | -1,363 | -683 |
Cash flows from investing activities: | ||||||
Proceeds from sale of fixed assets | ||||||
- | 0 | - | - | - | - | - |
Acquisition of business, net of cash acquired | ||||||
- | - | - | 495 | - | - | - |
Purchase of property and equipment | ||||||
51 | - | 14 | 6 | 83 | 15 | 15 |
Net cash provided by (used in) investing activities | ||||||
-51 | 0 | -14 | -502 | - | - | - |
Net Cash Used in Investing Activities | ||||||
- | - | - | - | -83 | -15 | -15 |
Cash flows from financing activities: | ||||||
Change in current portion of capital lease | ||||||
- | - | 10 | - | - | - | - |
Proceeds from the issuance of common stock | ||||||
7,683 | 1,635 | 24,659 | 19,863 | - | - | - |
Proceeds from issuance of preferred stock | ||||||
- | - | - | - | 12,500 | - | - |
Proceeds from the exercise of warrants | ||||||
2,090 | 142 | 85 | - | - | - | - |
Issuance of common stock via private placement | ||||||
- | - | - | - | - | 3,225 | 3,225 |
Proceeds from stock options exercised | ||||||
- | - | 31 | 34 | 1 | - | - |
Proceeds from debt financing | ||||||
1,250 | 2,000 | - | - | - | - | - |
Repayment of debt financing | ||||||
1,250 | 668 | - | - | - | - | - |
Payment of contingent consideration milestone | ||||||
- | 1,000 | - | - | - | - | - |
Repayment of convertible debt | ||||||
1,100 | - | - | - | - | - | - |
Net cash provided by financing activities | ||||||
18,707 | 12,523 | 24,765 | 19,898 | - | - | - |
Net increase (decrease) in cash | ||||||
11,090 | -3,121 | - | - | - | - | - |
Fees and expense - private placement | ||||||
- | - | - | - | - | 15 | - |
Fees and expenses - private placement | ||||||
- | - | - | - | - | - | 15 |
Borrowings under demand note payable to Synergy | ||||||
- | - | - | - | - | 350 | 450 |
Repayments under demand note payable to Synergy | ||||||
- | - | - | - | - | 450 | 450 |
Net Cash provided by Financing Activities | ||||||
- | - | - | - | 12,501 | 3,109 | 3,209 |
Net decrease in cash | ||||||
- | - | 5,578 | 2,840 | 2,745 | - | - |
Supplementary disclosure of cash flow information: | ||||||
Cash paid for interest | ||||||
26 | 131 | - | - | - | 12 | 13 |
Net increase in cash | ||||||
- | - | - | - | - | 1,731 | 2,510 |
Supplementary disclosure of non-cash financing activities: | ||||||
Stock issued to employees in lieu of cash payment for accrued bonus | ||||||
- | 296 | - | - | - | - | - |
Issuance of common stock in conjunction with milestone payment | ||||||
- | 55 | - | - | - | - | - |
Derecognition of Series C warrants exercised | ||||||
- | 34 | 75 | - | - | - | - |
Accretion of Series C, D and E Preferred stock discount upon conversion | ||||||
4,674 | - | - | - | - | - | - |
Value of warrants exchanged for common stock | ||||||
- | - | - | - | 4,863 | - | - |
Fair value of warrants issued in conjunction with common stock offering | ||||||
- | 5,091 | 3,976 | 5,922 | - | - | - |
Issuance of common stock for debt redemption | ||||||
500 | - | - | - | - | - | - |
Adoption of Lease accounting | ||||||
773 | - | - | - | - | - | - |
Warrants issued to placement agent | ||||||
293 | 221 | - | - | - | - | - |
Deemed dividend on preferred stock beneficial conversion feature | ||||||
- | - | - | - | 7,844 | - | - |
Series C | ||||||
Proceeds from issuance of preferred stock | ||||||
- | 10,414 | - | - | - | - | - |
Conversion of convertible preferred stock | ||||||
147 | 4,680 | - | - | - | - | - |
Beneficial conversion factor of preferred stock accreted as deemed dividend | ||||||
768 | 3,771 | - | - | - | - | - |
Series D | ||||||
Proceeds from issuance of preferred stock | ||||||
403 | - | - | - | - | - | - |
Conversion of convertible preferred stock | ||||||
521 | - | - | - | - | - | - |
Accretion of Series C, D and E Preferred stock discount upon conversion | ||||||
286 | - | - | - | - | - | - |
Series E | ||||||
Proceeds from issuance of preferred stock | ||||||
9,649 | - | - | - | - | - | - |
Conversion of convertible preferred stock | ||||||
10,570 | - | - | - | - | - | - |
Accretion of Series C, D and E Preferred stock discount upon conversion | ||||||
4,311 | - | - | - | - | - | - |
Series A | ||||||
Conversion of convertible preferred stock | ||||||
- | 184 | - | - | - | - | - |